fda compounding glp-1 enforcement news New project announcement: HHS‑OIG is taking a closer look at FDA's oversight of compounded GLP‑1 drugs. Although shortages ended in 2025, some facilities may still be producing these drugs at scale. Our FDA GLP-1 Compounding Crackdown

Heres what genuinely moves the needle for you, in order: Physician authority on every page Named providers, real credentials, accountable content

If compounded semaglutide is kept past its expiration date, it might: Undergo drug breakdown: The active ingredients may deteriorate

These impairments not only compromise fertility but may also pose long-term risks to offspring health via genetic and epigenetic mechanisms

The legal process surrounding these acetaminophen lawsuits involves several stages, including filing complaints, discovery, pretrial proceedings, and potential trials

Status: SubmittedDenverDA approval in late 2025